Mirum Pharmaceuticals Inc Revenue per Employee (MIRM), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Mirum Pharmaceuticals Inc   (NASDAQ: MIRM)
 

Mirum Pharmaceuticals Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 37.92% in the second quarter 2026, year on year to cumulative value of $618 million, Mirum Pharmaceuticals Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,661,470, this marks a new company high.
Within the Healthcare sector Employees of 49 other companies have achieved higher revenue per employee. While revenue/employee total ranking has improved so far to 572, from total ranking in previous quarter at 798. Mirum Pharmaceuticals Inc has 372 employees.


What is Sales per Employee Ratio?







MIRM Revenue per Employee (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Revenue Change 37.92 % 43.28 % 49.81 % 47.17 % 64.09 %
Sales per Employee (TTM) $ 1,661,470 1,531,207 1,401,376 1,268,263 1,153,659
MIRM's Total Ranking # 572 # 798 # 695 # 759 # 849
Seq. Revenue Change 10.23 % 7.35 % 11.97 % 4.09 % 14.52 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 34
Healthcare Sector # 50
Overall Market # 572

Revenue per Employee Statistics
High Average Low
$ 1,661,470 $ 726,409 $ 86,102
(Jun 30 2026)   (Mar 31 2022)



Financial Statements
Mirum Pharmaceuticals Inc 's Revenue MRQ $ 176 Millions Visit MIRM's Income Statement
Mirum Pharmaceuticals Inc 's Revenues TTM $ 618 Millions Visit MIRM's aggregate revenue growth
What are MIRM's Sales? Visit MIRM's Sales by Segment




Other Ratios
Mirum Pharmaceuticals Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
MIRM's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for MIRM's Competitors
Revenue per Employee for MIRM's Suppliers
Revenue per Employee for MIRM's Customers

You may also want to know
MIRM's Sales Growth Rates MIRM's Pe Price to earnings ratio MIRM's Receivables Turnover Ratio MIRM's Stock Quote
MIRM's Net Income Growth Rates MIRM's Ps Price to Sales ratio MIRM's Sales per Employee MIRM's Asset Turnover Ratio
MIRM's Net Margin MIRM's Pb Price to Book ratio MIRM's Financial Strength Ratios MIRM's Dividend Payout Ratio
Date modified: 2026-09-08T15:11:45+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Aurinia Pharmaceuticals Inc   2,433,648.44 $ 311.507  Million 128 
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Biocryst Pharmaceuticals Inc   2,162,328.74 $ 940.613  Million 435 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Zevra Therapeutics Inc   2,112,377.05 $ 128.855  Million 61 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Tg Therapeutics Inc   2,003,849.62 $ 799.536  Million 399 
Prestige Consumer Healthcare Inc   1,938,521.05 $ 1,104.957  Million 570 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Gilead Sciences Inc   1,791,588.24 $ 30,457.000  Million 17,000 
Collegium Pharmaceutical Inc   1,777,172.58 $ 751.744  Million 423 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 
Xenetic Biosciences Inc   1,630,388.50 $ 3.261  Million
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 
Progyny Inc   1,531,890.19 $ 1,311.298  Million 856 
Arcutis Biotherapeutics Inc   1,310,680.79 $ 463.981  Million 354 
Lantheus Holdings Inc   1,303,724.22 $ 1,555.343  Million 1,193 
Cue Biopharma Inc   1,298,413.79 $ 37.654  Million 29 
Puma Biotechnology Inc   1,291,865.92 $ 231.244  Million 179 
Arvinas Inc   1,287,398.37 $ 316.700  Million 246 
Travere Therapeutics Inc   1,189,798.79 $ 591.330  Million 497 
Heron Therapeutics Inc   1,183,648.44 $ 151.507  Million 128 
Journey Medical Corp  1,175,534.48 $ 68.181  Million 58 
Theravance Biopharma inc   1,159,011.11 $ 104.311  Million 90 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.